Teva Tells DC Circ. Ranbaxy Deserved Drug Revocation
Teva Pharmaceuticals USA Inc. teamed up with another drugmaker Wednesday to argue in favor of the U.S. Food and Drug Administration pulling exclusivity periods for two Ranbaxy Inc. generics, telling the...To view the full article, register now.
Already a subscriber? Click here to view full article